Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreatic Carcinoma(LAPC)”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)UnknownNCT06202014
What this trial is testing

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Who this might be right for
Pancreatic CancerRadiotherapyEnvafolimab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Testing effectiveness (Phase 2)UnknownNCT06153368
What this trial is testing

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Large-scale testing (Phase 3)Looking for participantsNCT03257033
What this trial is testing

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Who this might be right for
Locally Advanced Pancreatic Cancer
RenovoRx 190
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Ended earlyNCT00831493
What this trial is testing

Vorinostat Plus Radiation Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Early research (Phase 1)Not Yet RecruitingNCT06217666
What this trial is testing

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Who this might be right for
Pancreatic Adenocarcinoma
Haoming (Carl) Qiu 24
Testing effectiveness (Phase 2)Study completedNCT03861702
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Who this might be right for
Locally Advanced Pancreatic Carcinoma(LAPC)
Nelson Yee 28
Not applicableEnded earlyNCT01683422
What this trial is testing

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Loma Linda University 9
Large-scale testing (Phase 3)Active Not RecruitingNCT03899636
What this trial is testing

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

Who this might be right for
Stage III Pancreatic Cancer
Angiodynamics, Inc. 528
Testing effectiveness (Phase 2)Study completedNCT01939665
What this trial is testing

PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma

Who this might be right for
Locally Advanced Pancreatic Carcinoma (LAPC)Non-metastasized Unresectable Pancreatic CarcinomaPancreatic Cancer
Amsterdam UMC, location VUmc 50
Testing effectiveness (Phase 2)Study completedNCT01397019
What this trial is testing

Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 56
Testing effectiveness (Phase 2)Looking for participantsNCT07306273
What this trial is testing

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02301143
What this trial is testing

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

Who this might be right for
Pancreatic Neoplasms
Celgene 107
Testing effectiveness (Phase 2)Temporarily pausedNCT05494697
What this trial is testing

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

Who this might be right for
Pancreatic Cancer
AIM ImmunoTech Inc. 90
Large-scale testing (Phase 3)Looking for participantsNCT06714604
What this trial is testing

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas Cancer+3 more
Sahlgrenska University Hospital 432
Not applicableStudy completedNCT02791503
What this trial is testing

CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy

Who this might be right for
Pancreatic Neoplasm
Dr. M.R. Meijerink 74
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07306286
What this trial is testing

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07595835
What this trial is testing

CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.R. Meijerink 20
Next Page